Advanced Enzyme Technologies

Advanced Enzyme Technologies Current Assets

The Current Assets of Advanced Enzyme Technologies (ADVENZYMES.NS) as of Oct 19, 2026 is 8.98 B INR. In the previous year, Current Assets was 8.84 B INR — a change of 1.60% (higher).

Current Assets

8.98 BINR

YoY

1.60%

Last updated:

Current Assets of Advanced Enzyme Technologies is 2026 8.98 B INR. Current Assets of Advanced Enzyme Technologies was 2025 8.84 B INR. It decreases by 1.60% higher compared to the previous year.

The Advanced Enzyme Technologies Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
2.80 B INR
Jan 1, 2020
3.77 B INR
Jan 1, 2021
6.00 B INR
Jan 1, 2022
6.08 B INR
Jan 1, 2023
7.26 B INR
Jan 1, 2024
8.13 B INR
Jan 1, 2025
8.84 B INR
Jan 1, 2026
8.98 B INR
The Advanced Enzyme Technologies Current Assets history
YEARCurrent AssetsYoY
8.98 BINR+1.60%
8.84 BINR+8.73%
8.13 BINR+12.03%
7.26 BINR+19.29%
6.08 BINR+1.37%
6.00 BINR+59.22%
3.77 BINR+34.42%
2.80 BINR+33.73%
2.10 BINR+7.01%
1.96 BINR+32.91%
1.47 BINR-1.64%
1.50 BINR+13.88%
1.32 BINR-4.72%
1.38 BINR+21.77%
1.13 BINR+27.41%
890.52 MINR+203.40%
293.51 MINR+26.73%
231.60 MINR+1.91%
227.25 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Advanced Enzyme Technologies Stock analysis

What does Advanced Enzyme Technologies do? Advanced Enzyme Technologies Ltd is a company based in Thane, India, operating within the Materials sector, specifically in the Chemicals industry. The company focuses on the research, development, manufacture, and sale of enzyme products, employing 338 full-time staff. It completed its initial public offering (IPO) on August 1, 2016. Advanced Enzyme Technologies develops and markets a range of enzyme-based products derived from indigenous sources, including over 68 types of enzymes and probiotics. The company serves various industries, such as human health care and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing, malting, grain processing, protein modification, dairy processing, textile processing, and others. Its product portfolio includes solutions for human nutrition featuring serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition products like DigeGrain X, DigeGrain XL, and DigeGrain M; food processing solutions for dairy and cheese, as well as yeast processing; and non-food applications in textile processing, leather, and biofuels. The company also provides services related to oils and fats processing, including oil extraction and refining. Advanced Enzyme Technologies Ltd maintains a website at https://www.advancedenzymes.com/ for further information about its operations and offerings. Advanced Enzyme Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Advanced Enzyme Technologies stock

Current Assets of Advanced Enzyme Technologies is 8.98 B INR in 2026.

Current Assets of Advanced Enzyme Technologies changed from 8.84 B INR to 8.98 B INR, representing a 1.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Advanced Enzyme Technologies since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Advanced Enzyme Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Advanced Enzyme Technologies

All Key Metrics — Advanced Enzyme Technologies